HIV/AIDS Diagnostics Market: Industry Analysis and Forecast

HIV/AIDS Diagnostics Market Size by Product type, Test Type, End user, Region – Revenue Pool Analysis, Margin Structure Assessment, Capital Flow Trends, Competitive Benchmarking & Forecast to 2029

10.12%

CAGR (2022-2029)

2.6 USD Bn.

Market Size

310

Report Pages

136

Market Tables

Overview

HIV/AIDS Diagnostics Market is expected to reach US$ 5.63 Bn. at a CAGR of 10.12% during the forecast period 2029.

There is a growing demand within the global health community to find ways to improve access to diagnostics for HIV without diminishing the quality of patient care. HIV-infected individuals require testing for initial diagnosis, staging, and ongoing monitoring throughout treatment. For low and middle-income country populations it can be a challenge to achieve a timely diagnosis of infants under 18 months, viral load (VL) monitoring, and CD4 staging. The stage of HIV infection can be identified by clinical symptoms and more accurately by laboratory tests. These tests can be used to identify persons at high risk of disease progression, detect asymptomatic patients, and guide clinical decision making such as when to initiate ART and detect treatment failure.

Global HIV-AIDS Diagnostics Market

To know about the Research Methodology :- Request Free Sample Report

Advances in POC testing for EID, CD4, and VL are likely to bring about significant changes in access to quality health care. At the same time, advances in high-volume testing also are becoming available, allowing cost-effective consolidation of testing in high-volume centers. In addition, a number of modular or open molecular platforms are available. To improve the accessibility of high-quality antiretroviral therapy (ART), there is a growing demand for simple, affordable, reliable, and quality-assured point-of-care (POC) diagnostics. At the same time, simplifying diagnostic technologies may reduce the cost of diagnosing and monitoring the treatment of people living with HIV without diminishing the quality of care. In addition, rapid tests are emerging that can be used for self-testing, proposed as an additional approach to help to identify people living with HIV not reached by current testing models. As per current guidance from WHO, all reactive self-test must be confirmed, receiving further testing from a trained provider. All the above are key factors that are responsible for the market growth.

The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the Global HIV/AIDS Diagnostics Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges.

The report has profiled fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.

HIV/AIDS Diagnostics Market Segment Analysis

Based on product type, the market is segmented into consumables, instruments, and software and services. The consumables segment held a larger share of xx% in 2021 and is expected to grow at a significant CAGR of xx% during the forecast period. The consumables segment includes assays, kits, reagents, and other consumables necessary for testing. The increasing prevalence of HIV/AIDS is in turn growing the demand for these consumables by doctors, physicians, medicals, and other healthcare professionals. Also, the increasing initiatives undertaken by governments to increase awareness about the syndrome are also augmenting the market growth. Various campaigns and check-up camps organized by government and non-government organizations about kits and other consumables are augmenting the market growth.

Based on test type, the CD4 tests segment is expected to account for the largest share. CD4 cell count is the primary indicator to assess the strength of the immune system and overall health and will remain a key parameter in HIV care for establishing baselines for ART initiation and risk stratification, along with monitoring immune recovery through the early stages of ARV clinical management. CD4 testing will also retain an important role in the management of opportunistic infections, drug toxicity, and virological failure. Laboratory-based CD4 platforms account for virtually the entire market for CD4 testing. Laboratory-based CD4 testing has the lowest cost per test of US$ 3–7.

HIV/AIDS Diagnostics Market Regional Insights:

North America accounted for the largest share of xx% in 2021, the reason being the rising prevalence of HIV/AIDS cases. According to WHO, around 1.1 million people are living with HIV in the United States of America (USA). Well-established healthcare infrastructure, ease of availability is also a key driver affecting the market growth. Investments by key players in this field have boosted the market growth. The rising adoption of technologically advanced diagnostic systems and increasing awareness is rapidly growing the market.

The Asia Pacific is also expected to witness significant growth during the forecast period due to the allocation of a large amount of healthcare expenditure for hospitals.

HIV/AIDS Diagnostics Market Scope: Inquire before buying:

Global HIV/AIDS Diagnostics Market
Report Coverage	Details
Base Year:	2021	Forecast Period:	2022-2029
Historical Data:	2017 to 2021	Market Size in 2021:	US $ 2.60 Bn.
Forecast Period 2022 to 2029 CAGR:	10.12%	Market Size in 2029:	US $ 5.63Bn.
Segments Covered:	by Product type	• Consumables • Instruments • Software’s and Services
	by Test Type	• Antibody tests  HIV-1 Screening tests  HIV-1 confirmatory tests  HIV-2  O diagnostic tests • Viral Load (VL) tests • CD4 tests • Others
	by End user	• Hospitals • Diagnostic laboratories • Others

HIV/AIDS Diagnostics Market Key Players:

• Siemens AG
• Roche Diagnostics
• Abbott Laboratories
• Danaher Corporation
• Thermo Fisher Scientific Inc
• Merck KGaA
• Becton
• Dickinson and Company
• Hologic, Inc
• Alere Inc
• Bio-rad Laboratories
• F. Hoffman-La Roche Ltd
• OraSure Technologies, Inc
• Siemens Healthineers
• Chembio Diagnostic Systems

Frequently Asked Questions:

1. Which region has the largest share in Global HIV/AIDS Diagnostics Market?
Ans: North America region holds the highest share in 2021.

2. What is the growth rate of Global HIV/AIDS Diagnostics Market?
Ans: The Global HIV/AIDS Diagnostics Market is growing at a CAGR of 10.12% during forecasting period 2022-2029.

3. What is scope of the Global HIV/AIDS Diagnostics Market report?
Ans: Global HIV/AIDS DIAGNOSTICS Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global HIV/AIDS Diagnostics Market?
Ans: The important key players in the Global HIV/AIDS DIAGNOSTICS Market are –
Siemens AG,Roche Diagnostics,Abbott Laboratories,Danaher Corporation,Thermo Fisher Scientific Inc,Merck KGaA,Becton,Dickinson and Company,Hologic, Inc,Alere Inc,Bio-rad Laboratories,F. Hoffman-La Roche Ltd,OraSure Technologies, Inc,Siemens Healthineers,Chembio Diagnostic Systems

5. What is the study period of this market?
Ans: The Global HIV/AIDS DIAGNOSTICS Market is studied from 2021 to 2029.

Global HIV/AIDS Diagnostics Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: HIV/AIDS DIAGNOSTICS Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global HIV/AIDS DIAGNOSTICS Market Analysis and Forecast 6.1. HIV/AIDS DIAGNOSTICS Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global HIV/AIDS DIAGNOSTICS Market Analysis and Forecast, By Product type 7.1. Introduction and Definition 7.2. Key Findings 7.3. HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Product type 7.4. HIV/AIDS DIAGNOSTICS Market Size (US$ Mn) Forecast, By Product type 7.5. HIV/AIDS DIAGNOSTICS Market Analysis, By Product type 7.6. HIV/AIDS DIAGNOSTICS Market Attractiveness Analysis, By Product type 8. Global HIV/AIDS DIAGNOSTICS Market Analysis and Forecast, By Test Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Test Type 8.4. HIV/AIDS DIAGNOSTICS Market Size (US$ Mn) Forecast, By Test Type 8.5. HIV/AIDS DIAGNOSTICS Market Analysis, By Test Type 8.6. HIV/AIDS DIAGNOSTICS Market Attractiveness Analysis, By Test Type 9. Global HIV/AIDS DIAGNOSTICS Market Analysis and Forecast By End user 9.1. Introduction and Definition 9.2. Key Findings 9.3. HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By End user 9.4. HIV/AIDS DIAGNOSTICS Market Size (US$ Mn) Forecast, By End user 9.5. HIV/AIDS DIAGNOSTICS Market Analysis, By End user 9.6. HIV/AIDS DIAGNOSTICS Market Attractiveness Analysis, By End user 10. Global HIV/AIDS DIAGNOSTICS Market Analysis, By Region 10.1. HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Region 10.2. HIV/AIDS DIAGNOSTICS Market Size (US$ Mn) Forecast, By Region 10.3. HIV/AIDS DIAGNOSTICS Market Attractiveness Analysis, By Region 11. North America HIV/AIDS DIAGNOSTICS Market Analysis 11.1. Key Findings 11.2. North America HIV/AIDS DIAGNOSTICS Market Overview 11.3. North America HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Product type 11.4. North America HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 11.4.1. Consumables 11.4.2. Instruments 11.4.3. Software’s and Services 11.5. North America HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Test Type 11.6. North America HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 11.6.1. Antibody tests 11.6.2. Viral Load (VL) tests 11.6.3. CD4 tests 11.6.4. Others 11.7. North America HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By End user 11.8. North America HIV/AIDS DIAGNOSTICS Market Forecast, By End user 11.8.1. Hospitals 11.8.2. Diagnostic laboratories 11.8.3. Others 11.9. North America HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Country 11.10. North America HIV/AIDS DIAGNOSTICS Market Forecast, By Country 11.10.1. U.S. 11.10.2. Canada 11.10.3. Mexico 11.11. North America HIV/AIDS DIAGNOSTICS Market Analysis, By Country 11.12. U.S. HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 11.12.1. Consumables 11.12.2. Instruments 11.12.3. Software’s and Services 11.13. U.S. HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 11.13.1. Antibody tests 11.13.2. Viral Load (VL) tests 11.13.3. CD4 tests 11.13.4. Others 11.14. U.S. HIV/AIDS DIAGNOSTICS Market Forecast, By End user 11.14.1. Hospitals 11.14.2. Diagnostic laboratories 11.14.3. Others 11.15. Canada HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 11.15.1. Consumables 11.15.2. Instruments 11.15.3. Software’s and Services 11.16. Canada HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 11.16.1. Antibody tests 11.16.2. Viral Load (VL) tests 11.16.3. CD4 tests 11.16.4. Others 11.17. Canada HIV/AIDS DIAGNOSTICS Market Forecast, By End user 11.17.1. Hospitals 11.17.2. Diagnostic laboratories 11.17.3. Others 11.18. Mexico HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 11.18.1. Consumables 11.18.2. Instruments 11.18.3. Software’s and Services 11.19. Mexico HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 11.19.1. Antibody tests 11.19.2. Viral Load (VL) tests 11.19.3. CD4 tests 11.19.4. Others 11.20. Mexico HIV/AIDS DIAGNOSTICS Market Forecast, By End user 11.20.1. Hospitals 11.20.2. Diagnostic laboratories 11.20.3. Others 11.21. North America HIV/AIDS DIAGNOSTICS Market Attractiveness Analysis 11.21.1. By Product type 11.21.2. By Test Type 11.21.3. By End user 11.22. PEST Analysis 11.23. Key Trends 11.24. Key Developments 12. Europe HIV/AIDS DIAGNOSTICS Market Analysis 12.1. Key Findings 12.2. Europe HIV/AIDS DIAGNOSTICS Market Overview 12.3. Europe HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Product type 12.4. Europe HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 12.4.1. Consumables 12.4.2. Instruments 12.4.3. Software’s and Services 12.5. Europe HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Test Type 12.6. Europe HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 12.6.1. Antibody tests 12.6.2. Viral Load (VL) tests 12.6.3. CD4 tests 12.6.4. Others 12.7. Europe HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By End user 12.8. Europe HIV/AIDS DIAGNOSTICS Market Forecast, By End user 12.8.1. Hospitals 12.8.2. Diagnostic laboratories 12.8.3. Others 12.9. Europe HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Country 12.10. Europe HIV/AIDS DIAGNOSTICS Market Forecast, By Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Sweden 12.10.7. CIS countries 12.10.8. Rest of Europe 12.11. Germany HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 12.11.1. Consumables 12.11.2. Instruments 12.11.3. Software’s and Services 12.12. Germany HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 12.12.1. Antibody tests 12.12.2. Viral Load (VL) tests 12.12.3. CD4 tests 12.12.4. Others 12.13. Germany HIV/AIDS DIAGNOSTICS Market Forecast, By End user 12.13.1. Hospitals 12.13.2. Diagnostic laboratories 12.13.3. Others 12.14. U.K. HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 12.14.1. Consumables 12.14.2. Instruments 12.14.3. Software’s and Services 12.15. U.K. HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 12.15.1. Antibody tests 12.15.2. Viral Load (VL) tests 12.15.3. CD4 tests 12.15.4. Others 12.16. U.K. HIV/AIDS DIAGNOSTICS Market Forecast, By End user 12.16.1. Hospitals 12.16.2. Diagnostic laboratories 12.16.3. Others 12.17. France HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 12.17.1. Consumables 12.17.2. Instruments 12.17.3. Software’s and Services 12.18. France HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 12.18.1. Antibody tests 12.18.2. Viral Load (VL) tests 12.18.3. CD4 tests 12.18.4. Others 12.19. France HIV/AIDS DIAGNOSTICS Market Forecast, By End user 12.19.1. Hospitals 12.19.2. Diagnostic laboratories 12.19.3. Others 12.20. Italy HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 12.20.1. Consumables 12.20.2. Instruments 12.20.3. Software’s and Services 12.21. Italy HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 12.21.1. Antibody tests 12.21.2. Viral Load (VL) tests 12.21.3. CD4 tests 12.21.4. Others 12.22. Italy HIV/AIDS DIAGNOSTICS Market Forecast, By End user 12.22.1. Hospitals 12.22.2. Diagnostic laboratories 12.22.3. Others 12.23. Spain HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 12.23.1. Consumables 12.23.2. Instruments 12.23.3. Software’s and Services 12.24. Spain HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 12.24.1. Antibody tests 12.24.2. Viral Load (VL) tests 12.24.3. CD4 tests 12.24.4. Others 12.25. Spain HIV/AIDS DIAGNOSTICS Market Forecast, By End user 12.25.1. Hospitals 12.25.2. Diagnostic laboratories 12.25.3. Others 12.26. Sweden HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 12.26.1. Consumables 12.26.2. Instruments 12.26.3. Software’s and Services 12.27. Sweden HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 12.27.1. Antibody tests 12.27.2. Viral Load (VL) tests 12.27.3. CD4 tests 12.27.4. Others 12.28. Sweden HIV/AIDS DIAGNOSTICS Market Forecast, By End user 12.28.1. Hospitals 12.28.2. Diagnostic laboratories 12.28.3. Others 12.29. CIS countries HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 12.29.1. Consumables 12.29.2. Instruments 12.29.3. Software’s and Services 12.30. CIS countries HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 12.30.1. Antibody tests 12.30.2. Viral Load (VL) tests 12.30.3. CD4 tests 12.30.4. Others 12.31. CIS countries HIV/AIDS DIAGNOSTICS Market Forecast, By End user 12.31.1. Hospitals 12.31.2. Diagnostic laboratories 12.31.3. Others 12.32. Rest of Europe HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 12.32.1. Consumables 12.32.2. Instruments 12.32.3. Software’s and Services 12.33. Rest of Europe HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 12.33.1. Antibody tests 12.33.2. Viral Load (VL) tests 12.33.3. CD4 tests 12.33.4. Others 12.34. Rest of Europe HIV/AIDS DIAGNOSTICS Market Forecast, By End user 12.34.1. Hospitals 12.34.2. Diagnostic laboratories 12.34.3. Others 12.35. Europe HIV/AIDS DIAGNOSTICS Market Attractiveness Analysis 12.35.1. By Test Type 12.35.2. By Product type 12.35.3. By End user 12.36. PEST Analysis 12.37. Key Trends 12.38. Key Developments 13. Asia Pacific HIV/AIDS DIAGNOSTICS Market Analysis 13.1. Key Findings 13.2. Asia Pacific HIV/AIDS DIAGNOSTICS Market Overview 13.3. Asia Pacific HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Product type 13.4. Asia Pacific HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 13.4.1. Consumables 13.4.2. Instruments 13.4.3. Software’s and Services 13.5. Asia Pacific HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Test Type 13.6. Asia Pacific HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 13.6.1. Antibody tests 13.6.2. Viral Load (VL) tests 13.6.3. CD4 tests 13.6.4. Others 13.7. Asia Pacific HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By End user 13.8. Asia Pacific HIV/AIDS DIAGNOSTICS Market Forecast, By End user 13.8.1. Hospitals 13.8.2. Diagnostic laboratories 13.8.3. Others 13.9. Asia Pacific HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Country 13.10. Asia Pacific HIV/AIDS DIAGNOSTICS Market Forecast, By Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. South Korea 13.10.5. Australia 13.10.6. ASEAN 13.10.7. Rest of Asia Pacific 13.11. Asia Pacific HIV/AIDS DIAGNOSTICS Market Analysis, By Country 13.12. China HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 13.12.1. Consumables 13.12.2. Instruments 13.12.3. Software’s and Services 13.13. China HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 13.13.1. Antibody tests 13.13.2. Viral Load (VL) tests 13.13.3. CD4 tests 13.13.4. Others 13.14. China HIV/AIDS DIAGNOSTICS Market Forecast, By End user 13.14.1. Hospitals 13.14.2. Diagnostic laboratories 13.14.3. Others 13.15. India HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 13.15.1. Consumables 13.15.2. Instruments 13.15.3. Software’s and Services 13.16. India HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 13.16.1. Antibody tests 13.16.2. Viral Load (VL) tests 13.16.3. CD4 tests 13.16.4. Others 13.17. India HIV/AIDS DIAGNOSTICS Market Forecast, By End user 13.17.1. Hospitals 13.17.2. Diagnostic laboratories 13.17.3. Others 13.18. Japan HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 13.18.1. Consumables 13.18.2. Instruments 13.18.3. Software’s and Services 13.19. Japan HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 13.19.1. Antibody tests 13.19.2. Viral Load (VL) tests 13.19.3. CD4 tests 13.19.4. Others 13.20. Japan HIV/AIDS DIAGNOSTICS Market Forecast, By End user 13.20.1. Hospitals 13.20.2. Diagnostic laboratories 13.20.3. Others 13.21. South Korea HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 13.21.1. Consumables 13.21.2. Instruments 13.21.3. Software’s and Services 13.22. South Korea HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 13.22.1. Antibody tests 13.22.2. Viral Load (VL) tests 13.22.3. CD4 tests 13.22.4. Others 13.23. South Korea HIV/AIDS DIAGNOSTICS Market Forecast, By End user 13.23.1. Hospitals 13.23.2. Diagnostic laboratories 13.23.3. Others 13.24. Australia HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 13.24.1. Consumables 13.24.2. Instruments 13.24.3. Software’s and Services 13.25. Australia HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 13.25.1. Antibody tests 13.25.2. Viral Load (VL) tests 13.25.3. CD4 tests 13.25.4. Others 13.26. Australia HIV/AIDS DIAGNOSTICS Market Forecast, By End user 13.26.1. Hospitals 13.26.2. Diagnostic laboratories 13.26.3. Others 13.27. ASEAN HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 13.27.1. Consumables 13.27.2. Instruments 13.27.3. Software’s and Services 13.28. ASEAN HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 13.28.1. Antibody tests 13.28.2. Viral Load (VL) tests 13.28.3. CD4 tests 13.28.4. Others 13.29. ASEAN HIV/AIDS DIAGNOSTICS Market Forecast, By End user 13.29.1. Hospitals 13.29.2. Diagnostic laboratories 13.29.3. Others 13.30. Rest of Asia Pacific HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 13.30.1. Consumables 13.30.2. Instruments 13.30.3. Software’s and Services 13.31. Rest of Asia Pacific HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 13.31.1. Antibody tests 13.31.2. Viral Load (VL) tests 13.31.3. CD4 tests 13.31.4. Others 13.32. Rest of Asia Pacific HIV/AIDS DIAGNOSTICS Market Forecast, By End user 13.32.1. Hospitals 13.32.2. Diagnostic laboratories 13.32.3. Others 13.33. Asia Pacific HIV/AIDS DIAGNOSTICS Market Attractiveness Analysis 13.33.1. By Product type 13.33.2. By Test Type 13.33.3. By End user 13.34. PEST Analysis 13.35. Key Trends 13.36. Key Developments 14. Middle East & Africa HIV/AIDS DIAGNOSTICS Market Analysis 14.1. Key Findings 14.2. Middle East & Africa HIV/AIDS DIAGNOSTICS Market Overview 14.3. Middle East & Africa HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Product type 14.4. Middle East & Africa HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 14.4.1. Consumables 14.4.2. Instruments 14.4.3. Software’s and Services 14.5. Middle East & Africa HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Test Type 14.6. Middle East & Africa HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 14.6.1. Antibody tests 14.6.2. Viral Load (VL) tests 14.6.3. CD4 tests 14.6.4. Others 14.7. Middle East & Africa HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By End user 14.8. Middle East & Africa HIV/AIDS DIAGNOSTICS Market Forecast, By End user 14.8.1. Hospitals 14.8.2. Diagnostic laboratories 14.8.3. Others 14.9. Middle East & Africa HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Country 14.10. Middle East & Africa HIV/AIDS DIAGNOSTICS Market Forecast, By Country 14.10.1. GCC Countries 14.10.2. South Africa 14.10.3. Nigeria 14.10.4. Egypt 14.10.5. Rest of Middle East & Africa 14.11. Middle East & Africa HIV/AIDS DIAGNOSTICS Market Analysis, By Country 14.12. GCC Countries HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 14.12.1. Consumables 14.12.2. Instruments 14.12.3. Software’s and Services 14.13. GCC Countries HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 14.13.1. Antibody tests 14.13.2. Viral Load (VL) tests 14.13.3. CD4 tests 14.13.4. Others 14.14. GCC Countries HIV/AIDS DIAGNOSTICS Market Forecast, By End user 14.14.1. Hospitals 14.14.2. Diagnostic laboratories 14.14.3. Others 14.15. South Africa HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 14.15.1. Consumables 14.15.2. Instruments 14.15.3. Software’s and Services 14.16. South Africa HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 14.16.1. Antibody tests 14.16.2. Viral Load (VL) tests 14.16.3. CD4 tests 14.16.4. Others 14.17. South Africa HIV/AIDS DIAGNOSTICS Market Forecast, By End user 14.17.1. Hospitals 14.17.2. Diagnostic laboratories 14.17.3. Others 14.18. Nigeria HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 14.18.1. Consumables 14.18.2. Instruments 14.18.3. Software’s and Services 14.19. Nigeria HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 14.19.1. Antibody tests 14.19.2. Viral Load (VL) tests 14.19.3. CD4 tests 14.19.4. Others 14.20. Nigeria HIV/AIDS DIAGNOSTICS Market Forecast, By End user 14.20.1. Hospitals 14.20.2. Diagnostic laboratories 14.20.3. Others 14.21. Egypt HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 14.21.1. Consumables 14.21.2. Instruments 14.21.3. Software’s and Services 14.22. Egypt HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 14.22.1. Antibody tests 14.22.2. Viral Load (VL) tests 14.22.3. CD4 tests 14.22.4. Others 14.23. Egypt HIV/AIDS DIAGNOSTICS Market Forecast, By End user 14.23.1. Hospitals 14.23.2. Diagnostic laboratories 14.23.3. Others 14.24. Rest of Middle East & Africa HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 14.24.1. Consumables 14.24.2. Instruments 14.24.3. Software’s and Services 14.25. Rest of Middle East & Africa HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 14.25.1. Antibody tests 14.25.2. Viral Load (VL) tests 14.25.3. CD4 tests 14.25.4. Others 14.26. Rest of Middle East & Africa HIV/AIDS DIAGNOSTICS Market Forecast, By End user 14.26.1. Hospitals 14.26.2. Diagnostic laboratories 14.26.3. Others 14.27. Middle East & Africa HIV/AIDS DIAGNOSTICS Market Attractiveness Analysis 14.27.1. By Product type 14.27.2. By Test Type 14.27.3. By End user 14.28. PEST Analysis 14.29. Key Trends 14.30. Key Developments 15. South America HIV/AIDS DIAGNOSTICS Market Analysis 15.1. Key Findings 15.2. South America HIV/AIDS DIAGNOSTICS Market Overview 15.3. South America HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Product type 15.4. South America HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 15.4.1. Consumables 15.4.2. Instruments 15.4.3. Software’s and Services 15.5. South America HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Test Type 15.6. South America HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 15.6.1. Antibody tests 15.6.2. Viral Load (VL) tests 15.6.3. CD4 tests 15.6.4. Others 15.7. South America HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By End user 15.8. South America HIV/AIDS DIAGNOSTICS Market Forecast, By End user 15.8.1. Hospitals 15.8.2. Diagnostic laboratories 15.8.3. Others 15.9. South America HIV/AIDS DIAGNOSTICS Market Value Share Analysis, By Country 15.10. South America HIV/AIDS DIAGNOSTICS Market Forecast, By Country 15.10.1. Brazil 15.10.2. Colombia 15.10.3. Argentina 15.10.4. Rest of South America 15.11. South America HIV/AIDS DIAGNOSTICS Market Analysis, By Country 15.12. Brazil HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 15.12.1. Consumables 15.12.2. Instruments 15.12.3. Software’s and Services 15.13. Brazil HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 15.13.1. Antibody tests 15.13.2. Viral Load (VL) tests 15.13.3. CD4 tests 15.13.4. Others 15.14. Brazil HIV/AIDS DIAGNOSTICS Market Forecast, By End user 15.14.1. Hospitals 15.14.2. Diagnostic laboratories 15.14.3. Others 15.15. Colombia HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 15.15.1. Consumables 15.15.2. Instruments 15.15.3. Software’s and Services 15.16. Colombia HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 15.16.1. Antibody tests 15.16.2. Viral Load (VL) tests 15.16.3. CD4 tests 15.16.4. Others 15.17. Colombia HIV/AIDS DIAGNOSTICS Market Forecast, By End user 15.17.1. Hospitals 15.17.2. Diagnostic laboratories 15.17.3. Others 15.18. Argentina HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 15.18.1. Consumables 15.18.2. Instruments 15.18.3. Software’s and Services 15.19. Argentina HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 15.19.1. Antibody tests 15.19.2. Viral Load (VL) tests 15.19.3. CD4 tests 15.19.4. Others 15.20. Argentina HIV/AIDS DIAGNOSTICS Market Forecast, By End user 15.20.1. Hospitals 15.20.2. Diagnostic laboratories 15.20.3. Others 15.21. Rest of South America HIV/AIDS DIAGNOSTICS Market Forecast, By Product type 15.21.1. Consumables 15.21.2. Instruments 15.21.3. Software’s and Services 15.22. Rest of South America HIV/AIDS DIAGNOSTICS Market Forecast, By Test Type 15.22.1. Antibody tests 15.22.2. Viral Load (VL) tests 15.22.3. CD4 tests 15.22.4. Others 15.23. Rest of South America HIV/AIDS DIAGNOSTICS Market Forecast, By End user 15.23.1. Hospitals 15.23.2. Diagnostic laboratories 15.23.3. Others 15.24. South America HIV/AIDS DIAGNOSTICS Market Attractiveness Analysis 15.24.1. By Product type 15.24.2. By Test Type 15.24.3. By End user 15.25. PEST Analysis 15.26. Key Trends 15.27. Key Developments 16. Company Profiles 16.1. Market Share Analysis, By Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players By price, presence, market share, Test Type, and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A By Regions, Investment and Test Type 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Siemens AG 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Roche Diagnostics 16.3.3. Abbott Laboratories 16.3.4. Danaher Corporation 16.3.5. Thermo Fisher Scientific Inc 16.3.6. Merck KGaA 16.3.7. Becton 16.3.8. Dickinson and Company 16.3.9. Hologic, Inc 16.3.10. Alere Inc 16.3.11. Bio-rad Laboratories 16.3.12. F. Hoffman-La Roche Ltd 16.3.13. OraSure Technologies, Inc 16.3.14. Siemens Healthineers 16.3.15. Chembio Diagnostic Systems 16.3.16. Others

Global HIV/AIDS Diagnostics Market

Choose License Type